Background/Aims: Leptin is a hormone expressed by adipose tissue that regulates body energy homeostasis and weight loss by activating leptin receptors in the hypothalamus. Leptin receptors are also expressed in astrocytes. An anti-apoptosis effect of leptin in brain has recently been reported. However, the anti-apoptosis mechanism of leptin in the brain is unknown. Methods: To investigate whether leptin exerts protective effects against glutamateinduced apoptosis in astrocytes, we performed cell viability assays and apoptosis assays using rat primary astrocytes. Intracellular signaling pathways involved in anti-apoptosis effects of leptin were analyzed by immunoblotting together with a leptin mutant (S120A/T121A) with antagonist function and pharmacological inhibitors. Results: We found that glutamateinduced apoptosis in rat primary astrocytes was significantly decreased by treatment with leptin. Leptin inhibited glutamate-induced phosphorylation of ERK1/2 in astrocytes. The leptin S120A/T121A mutant did not inhibit glutamate-induced ERK1/2 phosphorylation and ERK1/2-mediated apoptosis. Conclusions: Collectively, our results provide initial evidence that leptin exerts an anti-apoptotic effect against glutamate toxicity through activation of intracellular signaling pathways which reverse glutamate-induced ERK1/2 phosphorylation in primary astrocytes. Therefore, our findings suggest that leptin might be considered a candidate for potential therapeutic applications in glutamate-induced brain excitotoxicity.
and 5% CO 2 at 95% relative humidity. After 2 weeks, the other cell types (oligodendrocytes and microglia) growing on the top of the astrocyte were detached from flasks by shaking and the medium was replaced with a medium containing 5% FBS. The attached cells were cultured for 1 more week. The cultured astrocytes were detached using trypsin/EDTA. Depending on the planned experiment, the primary astrocytes were reseeded on the following: 6 well tissue culture dishes (in a volume of 2 ml per dish) and 96-well plates (100 µl per well). Astrocyte-enriched cultures were assessed by staining for glial fibrillary acidic protein (GFAP).
Reagents and antibodies Recombinant rat leptin were purchased from PeproTech (Rocky Hill, NJ). Glutamate was purchased from Sigma-Aldrich, Co (St. Louis, MO, USA). Minimum essential medium (MEM) was purchased from WelGENE (WelGENE Inc. Daegu, Korea). Fetal bovine serum (FBS) was purchased from Gibco (Gibco, Grand Island, USA). Glutamate was purchased from Sigma. ERK 1/2, p-ERK 1/2, p38, p-p38, JNK, p-JNK, P-STAT3 (Tyr705), P-STAT3 (Ser727), AKT, P-AKT (Thr308), P-AKT (Ser473) to p-STAT3 (Tyr705), p-STAT3 (Ser727), AKT, p-AKT (Thr308), p-AKT (Ser473) antibodies were from Cell Signaling Technologies (Danvers, MA, USA). Tubulin antibody was obtained from Sigma-Aldrich, Co. Horseradish peroxidase (HRP)-conjugated secondary, P-JAK2 antibodies for immunoblotting were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). P-ObR (Tyr1141) antibodies were from signalway antibody Inc (College Park, Maryland, USA). The ERK inhibitor PD98059, JNK inhibitor SP600125, and p38 inhibitor SB203580 were purchased from Sigma-Aldrich, Co. Coomassie brilliant blue (CBB) staining solution was purchased from ATTO (ATTO, Tokyo, Japan).
Protein expression and purification
Recombinant leptin and leptin S120A/T121A mutant constructs were produced by consecutively subcloning the protein coding regions of leptin into the pRSETA vector (Invitrogen). Using these constructs, leptin and the leptin S120A/T121A mutant were overexpressed in Escherichia coli (BL21) as inclusion bodies, and the inclusion body proteins were purified as previously described [27, 28] . Then, the inclusion body proteins of wild type leptin and S120A/T121A mutant leptin were refolded as previously described [29, 30] . After refolding, wild type leptin and S120A/T121A mutant leptin proteins were purified by gelfiltration chromatography. All proteins were concentrated and PBS buffer was exchanged with a Centricon apparatus (Satorius Stedim Biotech, Germany). Endotoxins were removed via polymyxin B-agarose (SigmaAldrich). The Limulus Amebocyte Lysate (LAL) test was used to monitor endotoxin activity before and after endotoxin removal. Proteins were quantified using the bicinchoninic acid (BCA) assay, then filtered and stored at 4 °C until use.
Cell viability assays
Primary culture astrocyte cells were seeded on 96-well plates and incubated at 37 ℃ for 1 h in the presence or absence of various concentrations of leptin or glutamate. Then, 10 µL of 5 mg/mL of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) was added to each well and cells were cultured for 4 hours at 37 °C. The supernatant was aspirated and 0.5 M DMSO (Sigma-Aldrich co.) was added. The absorbance at 450 nm was detected with a microplate reader (VERSA max microplate reader, Molecular Devices, Sunnyvale, CA, USA).
Apoptosis assay
The proportion of apoptotic cells was measured by flow cytometry using a fluorescein isothiocyanate (FITC)-Annexin V apoptosis detection kit (BD Biosciences, San Jose, California). Primary cultured astrocytes were seeded in 6-well tissue culture plates and incubated overnight. After leptin pretreatment, cells were treated glutamate and then detached by trypsin. For annexin V/PI analysis, cells were harvested and stained with 5 μl annexin V and PI according to the manufacturer's instruction. Apoptosis levels were detected by on LSR-II flow cytometer (BD Biosciences).
Western blot analysis
Primary astrocytes were pretreated with leptin for 1 h and then treated with 10 mM glutamate for 1 h. Cell lysates were prepared with lysis buffer (10 mM Na 2 HPO 4 (pH7.2), 150 mM NaCl, 1 mM EDTA, 1% NP- . Membranes were blocked in 5% skim milk in Tris-buffered saline containing 0.1% Tween-20 (TBST) for 1 h at room temperature and then incubated with anti-ERK1/2, anti-phospho-ERK1/2 (Cell Signaling Technologies), anti-p38, anti-phospho-p38, anti-JNK, anti-phospho-JNK, and anti--tubulin antibodies overnight at 4°C. After three washes with 0.1% TBST, blots were incubated with goat anti-rabbit or anti-mouse peroxidaseconjugated secondary antibody (Santa Cruz Biotechnology) for 2 h and washed with 0.1% TBST. Western blot bands were developed by the enhanced chemiluminescence (ECL) method (GE healthcare, Buckinghamshire, UK).
Statistical analysis
Statistical analyses were performed using the Student's t test to compare between sample groups, and ANOVA was used to determine differences among multiple groups. Statistical significant differences were defined as P< 0.05.
Results

Glutamate induces extracellular signal-regulated kinases (ERK) 1/2-dependent apoptosis in rat primary astrocytes
Previous studies have demonstrated that pathologically excessive glutamate results in glutamate-induced astrocyte death through sustained ERK1/2 activation [25] . To determine whether glutamate influences the viability of rat primary astrocytes, an MTT assay was performed to assess the dose-dependent toxicity of glutamate. As shown in Fig. 1A , the viability of primary astrocytes was not affected by 1-h incubation with glutamate at up to 5 mM, but increasing concentrations of glutamate to doses of 10, 50, and 100 mM significantly decreased cell viability of primary astrocytes. At 10 mM of glutamate, cell viability reached ~30-40% of untreated control cells, so we used this concentration for all subsequent experiments. To determine whether reduced viability of astrocytes induced by glutamate was associated with apoptosis, we performed Annexin V-FITC/PI flow cytometry analysis. After 1-h incubation with glutamate at 10 mM, approximately 46.5% of astrocytes were detected as undergoing either cell early or late apoptosis (Fig. 1B) .
Saito and kinga demonstrated that ERK1/2 phosphorylation was induced by glutamate in cultured primary astrocytes [25] . To determine the early signaling events underlying glutamate-induced apoptosis of astrocytes, phosphorylation along the MAPK signaling pathway was analyzed using western blot analysis. At 1 h incubation with 1-10 mM of glutamate, phosphorylation of ERK1/2 and p38 was observed in a dose-dependent manner, but no changes were detected in JNK phosphorylation (Fig. 1C) . Using specific inhibitors for p38, ERK1/2, or JNK, we next examined the major signaling pathways responsible for glutamate-induced apoptosis in primary astrocytes. The cultured astrocytes were pretreated with the p38, ERK1/2, or JNK specific inhibitors SB203580, PD98059, or SP600125 respectively, before 1 h glutamate incubation (Fig. 1D) . Pretreatment with PD98059 significantly inhibited glutamate-induced apoptosis in primary astrocytes (43% reduction relative to the glutamate-treated group, P < 0.05). However, no significant change was observed in response to the JNK inhibitor and p38 inhibitor under the same conditions. These results indicate that glutamate induces apoptosis in rat primary astrocytes mainly via activation of ERK1/2.
Leptin suppresses glutamate-induced cytotoxicity in primary astrocytes
We next evaluated the effect of exogenous leptin on the cell viability and phosphorylation of MAPK signaling in rat primary astrocytes using the MTT assay and western blot analysis. As shown in Fig. 2A , the viability of primary astrocytes was not affected by 24 h incubation with leptin at up to 100 ng/ml. The level of phosphorylation of JNK and p38-MAPK was Cellular Physiology and Biochemistry
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also not changed in leptin-treated astrocytes compared to control while phosphorylation of ERK1/2 was slightly increased. To assess whether leptin treatment decreased glutamateinduced astrocyte apoptosis, we performed Annexin V-FITC/PI flow cytometry analysis. Similar results were obtained for the glutamate-treated group with regard to early and late apoptosis in primary astrocytes as in the previous experiments. However, after treatment with leptin at 1 µg/ml for 1 h together with glutamate, glutamate-induced apoptosis was significantly reduced (Fig. 2B) .
Leptin inhibits glutamate-induced phosphorylation of ERK1/2 in astrocytes
To elucidate the neuroprotective mechanisms of leptin against glutamate toxicity in astrocytes, we pretreated primary astrocytes with 1 µg/ml leptin for 1 h and analyzed MAPK signaling pathways, such as ERK1/2, p38, and JNK by immunoblotting. After leptin treatment, the level of phosphorylation of ERK1/2 was decreased in astrocytes compared with the glutamate-treated group, as determined by densitometry of immunoblots (Fig. 3 , lanes 2 and 6-8). However, treating astrocytes with leptin had no effect on p-JNK and p-p38. To address the upstream intracellular signaling pathways activated by leptin, we performed immunoblotting against p-ObR (Tyr1141), p-JAK2/STAT3 and p-Akt signaling pathways. We found that the level of p-ObR (Tyr1141), p-JAK2 and p-STAT3 was increased by leptin treatment in astrocytes similar to previous study [24] , while the level of p-AKT was not affected (Fig. 3A, lanes 3-5) . Interestingly, when we treated cells with glutamate and leptin together, leptin-induced ObR phosphorylation at Tyr1141 was slightly dephosphorylated by co-treatment of glutamate and leptin. Moreover, glutamate-induced phosphorylation of ERK1/2, AKT, ObR (Tyr1141), JAK2, and STAT3 were decreased by leptin treatment in a dose-dependent manner (Fig. 3A, lanes 6-8) . These results suggest that leptin modulates the extent of phosphorylation of leptin receptor ObR in the presence of glutamate and leads to suppression of glutamate-induced phosphorylation of signaling pathways especially ERK1/2 in primary astrocytes. astrocytes was assessed by immunoblotting similar to before. When leptin was administered with glutamate, we observed a significant decrease of p-ERK1/2, but not p-p38, compared with glutamate only-treated cells. However, cotreatment with S120A/T121A mutant leptin did not have an effect on ERK1/2 phosphorylation relative to the glutamate-treated group (Fig. 4D) . These results indicate that glutamate can induce astrocyte death and that leptin effectively inhibits glutamate-induced apoptosis in cultured primary astrocytes via LR.
Leptin has a protective effect against glutamate-induced apoptosis but is not effective against apoptosis induced by H 2 O 2 or CoCl 2
Previous studies demonstrated that hydrogen peroxide (H 2 O 2 ) and hypoxia (CoCl 2 ) induce apoptosis in cultured primary astrocytes [32] [33] [34] . Whether leptin has anti-apoptotic and necrotic effect on oxidative stress-induced apoptosis was evaluated using Annexin V-FITC/PI double staining monitored by flow cytometry. Primary astrocytes were pre-treated with 1 µg/ml leptin for 1 h, followed by treatment with 10 mM glutamate for 1 h. Increases in the number of dying cells in response to 10 mM glutamate was abolished when cells were pretreated with 1 µg/ml leptin. However, when cells were treated with H 2 O 2 or CoCl 2, the percentage of apoptotic and necrotic primary astrocytes was not changed by treatment with leptin (Fig. 5) . These results indicate that leptin exerts a protective effect on glutamateinduced apoptosis, but not on H 2 O 2 -or CoCl 2 -induced apoptosis in primary astrocytes. 
Discussion
In this study, we demonstrate the novel finding that leptin suppresses glutamateinduced cytotoxicity in primary astrocytes by modulating ERK1/2 phosphorylation. Glutamate induced the phosphorylation of ERK1/2 and subsequent p-ERK1/2-dependent cell death, while leptin treatment prevented glutamate cytotoxicity. The leptin antagonizing S120A/T121A mutant did not inhibit glutamate-induced ERK1/2 phosphorylation and ERK1/2-mediated cytotoxicity. These results indicate that leptin exerts cytoprotective effect against glutamate via leptin receptor through suppression of glutamate-induced ERK1/2 phosphorylation in primary astrocytes.
Leptin modulates various biological functions by binding to its receptors, which are expressed both centrally and peripherally. Leptin signaling acts predominantly through the LEP-Rb (OB-Rb) long isoform of the leptin receptor. The LR initiates downstream signaling when coupled with JAK, leading to activation of STAT-pathway, MAPK pathway (especially ERK1/2 signaling), and the phosphatidylinositol-3-kinase (PI 3 K)/Akt pathway [35, 36] . Recent research suggests that the neuroprotection exerted by leptin in the CNS is associated with modulation of the MAPK/CREB pathway [37] . The PI3K/Akt pathway was also found Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry to be the critical pathway for the mediation of leptin-induced neuroprotection [38] . This study is the first to evaluate the LR-mediated protective effect of leptin utilizing leptin S120A/T121A mutant which is known to behave as an antagonist by blocking activation of LR-mediated intracellular signaling pathways. We showed that the S120A/T121A leptin mutant failed to prevent glutamate-induced ERK1/2 phosphorylation and cytotoxicity in astrocytes, indicating the importance of the presence of leptin receptor, leptin-LR binding, and subsequent activation of intracellular signaling cascades for optimal anti-apoptotic activity of leptin (Fig. 4) . Astrocytes, which represent the most abundant glial cell in the brain, actively participate in various brain functions such as homeostasis, buffering function, neuroprotective function and neuronal differentiation [39] [40] [41] [42] . Recent studies demonstrated that LRs are expressed in the astrocytes and leptin and LRs play a role in various neuronal processes, including metabolism, neuroinflammation, morphology, and modulation of synaptic protein levels [43] [44] [45] [46] . A novel finding of this study was that leptin suppressed glutamate-induced cytotoxicity, but not H 2 O 2 -or CoCl 2 -induced cytotoxicity in primary astrocytes. Previously, it has been reported that leptin protects neuronal cells against ER stress through the PI3K-mTOR pathway and exerts neuroprotective activities and neurotrophic effects on neuronal damage after acute brain injuries [47, 48] . Leptin has proven to be an anticonvulsant in focal seizures model through the leptin receptor-mediated JAK2/PI3K signaling [49] . Shanley et al. demonstrated that leptin potently suppressed evoked epileptiform-like activity via PI3K activation of BK channels in rat hippocampal cells [50, 51] . When we tested the protective effect of leptin against exogenous treatment of glutamate, H 2 O 2 or CoCl 2 , we found that leptin had a protective effect specifically against glutamate-induced apoptosis, but is not effective against H 2 O 2 -or CoCl 2 -induced apoptosis using primary astrocytes (Fig. 5) . Together with previous reports demonstrating protective effect of leptin in neuronal cells, against seizure-induced neuronal injury our results for the protective effect of leptin in astrocytes collectively suggest that leptin may specifically contribute to the inhibition of glutamateinduced cytotoxicity both in neurons and glia.
Adding to previous findings on the neuroprotective effect of leptin, our results demonstrate for the first time that leptin, but not mutant leptin, effectively suppresses glutamate-induced cytotoxicity in primary astrocytes, as well. This suggests that leptin could be considered a potential candidate for the treatment of forms of brain damage associated with increased glutamate excitotoxicity, including hypoxia, ischemic brain injury, and epilepsy.
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